High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging.

Area of Science:

• Cardiovascular Biology
• Endothelial Function
• Molecular Medicine

Background:

• Soluble endoglin (sEng) is elevated in cardiovascular diseases like atherosclerosis and hypertension.
• sEng may exacerbate endothelial dysfunction, particularly with other risk factors such as aging.
• This study investigates the combined impact of high sEng and aging on vascular function.

Purpose of the Study:

• To determine if long-term exposure to high sEng levels exacerbates vascular dysfunction during aging in mice.
• To assess the effects of high sEng and aging on aortic contractility and endothelial signaling pathways.

Main Methods:

• Male transgenic mice with high plasma sEng (Sol-Eng+) and control littermates were studied over 12 months.
• Vascular function was assessed using wire myography to measure aortic contractility.
• Protein expression of endoglin (Eng), phosphorylated endothelial nitric oxide synthase (p-eNOS), and ID1 was analyzed via Western blot.

Main Results:

• The Sol-Eng+ group showed impaired aortic contractility after KCl and PGF2α stimulation compared to controls.
• No significant difference in endothelium-dependent relaxation to acetylcholine was observed between groups.
• Western blot revealed decreased Eng, p-eNOS, and ID1 protein expression in the Sol-Eng+ group, indicating reduced endoglin signaling.

Conclusions:

• Long-term high sEng exposure during aging alters aortic vasoconstriction and reduces eNOS phosphorylation.
• These results suggest sEng is a risk factor for age-related vascular dysfunction.
• sEng represents a potential therapeutic target for pharmacological intervention in vascular aging.